
TL;DR
Innovators under 35 are making significant strides in biotech, including a device to treat postpartum hemorrhage and flexible brain electrodes that minimize damage to brain tissue.
✦ Why It Matters
Explore partnerships with innovators to integrate new biotech solutions into healthcare practices.
Key Takeaways
Full Summary
This year's MIT Technology Review highlights young innovators in biotech, showcasing their groundbreaking contributions. Paschal Kija developed the Mkanda Salama device, which effectively treats postpartum hemorrhage, reducing maternal deaths in Tanzania by stopping bleeding in 73% of cases within 20 minutes.
Xiao Yang is creating ultra-small, flexible brain electrodes inspired by Japanese kirigami art, aiming to minimize damage to brain tissue. Sarah Grandinette's team personalized a gene-editing therapy for a baby with a rare genetic disorder, leading to a successful treatment.
Yuancheng Lu's reprogramming therapy has shown promise in reversing vision loss in aged mice and is now being tested in humans. Lastly, Samuel King utilized generative AI to design bacteriophages, which could lead to innovative drug development and pollution mitigation.
Related